Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Ra PharmaceuticalsAlkermesTaro Pharmaceutical IndustriesAgios PharmaceuticalsChemoCentryx
SymbolNASDAQ:RARXNASDAQ:ALKSNYSE:TARONASDAQ:AGIONASDAQ:CCXI
Price Information
Current Price$47.99$16.75$68.31$53.04$63.14
52 Week RangeHoldHoldBuyBuyBuy
Beat the Market™ Rank
Overall Score0.71.71.41.51.5
Analysis Score1.04.03.53.43.6
Community Score2.42.92.22.72.7
Dividend Score0.00.00.00.00.0
Ownership Score0.01.00.01.01.0
Earnings & Valuation Score0.00.61.30.60.0
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyBuy
Consensus Price Target$48.00$21.17$96.00$66.20$70.13
% Upside from Price Target0.02% upside26.41% upside40.54% upside24.81% upside11.06% upside
Trade Information
Market Cap$2.27 billion$2.57 billion$2.66 billion$3.61 billion$3.66 billion
Beta1.051.40.812.092.08
Average Volume1,158,5001,572,10930,801775,503621,328
Sales & Book Value
Annual Revenue$3 million$1.17 billion$644.77 million$117.91 million$36.13 million
Price / Sales757.112.274.0530.99108.09
CashflowN/A$0.60 per share$6.82 per shareN/AN/A
Price / CashN/A27.7910.01N/AN/A
Book Value$5.56 per share$6.70 per share$55.15 per share$9.08 per share$0.97 per share
Price / Book8.632.501.245.8465.09
Profitability
Net Income$-102,690,000.00$-196,620,000.00$244.24 million$-411,470,000.00$-55,490,000.00
EPS($2.31)$0.07$6.35($6.86)($0.98)
Trailing P/E RatioN/AN/A10.74N/AN/A
Forward P/E RatioN/AN/A∞N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-11.63%37.88%-205.20%-192.93%
Return on Equity (ROE)-44.61%4.99%11.94%-63.85%-100.55%
Return on Assets (ROA)-41.60%3.01%10.79%-45.21%-30.75%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%0.26%N/A0.17%0.40%
Current Ratio14.78%2.69%6.88%8.41%3.22%
Quick Ratio14.79%2.36%6.19%8.27%3.22%
Ownership Information
Institutional Ownership PercentageN/A97.90%11.60%97.73%69.97%
Insider Ownership Percentage4.30%4.49%13.80%3.16%9.30%
Miscellaneous
Employees722,2351,46448282
Shares Outstanding47.33 million158.74 million38.26 million68.89 million61.85 million
Next Earnings DateN/A7/23/2020 (Estimated)8/13/2020 (Estimated)8/6/2020 (Estimated)8/3/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.